These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31646579)

  • 1. MiRNA-337 leads to podocyte injury in mice with diabetic nephropathy.
    Zhao SM; Zhang T; Qiu Q; Xu C; Ma LJ; Liu J; Wang Z; Li YC; Huang J; Zhang M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8485-8492. PubMed ID: 31646579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-320a induces diabetic nephropathy via inhibiting MafB.
    He M; Wang J; Yin Z; Zhao Y; Hou H; Fan J; Li H; Wen Z; Tang J; Wang Y; Wang DW; Chen C
    Aging (Albany NY); 2019 May; 11(10):3055-3079. PubMed ID: 31102503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin.
    Zhang Y; Fukusumi Y; Kayaba M; Nakamura T; Sakamoto R; Ashizawa N; Kawachi H
    Nefrologia (Engl Ed); 2021; 41(5):539-547. PubMed ID: 36165136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
    Lee HS; Suh JY; Kang BC; Lee E
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy.
    Zhang H; Yan Y; Hu Q; Zhang X
    Life Sci; 2021 Feb; 266():118794. PubMed ID: 33232688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HOXA-AS2 inhibits inflammation and apoptosis in podocytes via sponging miRNA-302b-3p to upregulate TIMP3.
    Li X; Yu HM
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4963-4970. PubMed ID: 32432759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
    Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
    J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway.
    Chang J; Zheng J; Gao X; Dong H; Yu H; Huang M; Sun Z; Feng X
    Front Endocrinol (Lausanne); 2022; 13():888611. PubMed ID: 35721758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.
    Kim SH; Jang YW; Hwang P; Kim HJ; Han GY; Kim CW
    Exp Mol Med; 2012 Jan; 44(1):45-51. PubMed ID: 22056625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-124 is related to podocytic adhesive capacity damage in STZ-induced uninephrectomized diabetic rats.
    Li D; Lu Z; Jia J; Zheng Z; Lin S
    Kidney Blood Press Res; 2013; 37(4-5):422-31. PubMed ID: 24247359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
    Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
    Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy.
    Xu XH; Ding DF; Yong HJ; Dong CL; You N; Ye XL; Pan ML; Ma JH; You Q; Lu YB
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4952-4965. PubMed ID: 29164562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
    Loeffler I; Rüster C; Franke S; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2013 Sep; 305(6):F911-8. PubMed ID: 23825071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miRNA-155 Alleviates High Glucose-Induced Podocyte Inflammation by Targeting SIRT1 in Diabetic Mice.
    Wang X; Gao Y; Yi W; Qiao Y; Hu H; Wang Y; Hu Y; Wu S; Sun H; Zhang T
    J Diabetes Res; 2021; 2021():5597394. PubMed ID: 33748285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.